Franklin M Berger
Disclosed holdings of Franklin M Berger as of 2026-06-18: 536K shares of Atea Pharmaceuticals (AVIR), worth about $2.35M at the last close and 1 other…
What Franklin M Berger reported holding
As of the latest filing on , Franklin M Berger reported holding 536,097 shares of Atea Pharmaceuticals (AVIR), worth about $2.35M at the last close of $4 (Oct 19, 2026). Holdings are also on file at Retension Pharmaceuticals (RTSN); together they are worth about $2.72M. In the last 12 months, Franklin M Berger bought $120K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Atea Pharmaceuticals AVIR | 536,097 | 536K direct | $4 | $2.35M | Jun 18, 2026 |
| Retension Pharmaceuticals RTSN | 22,517 | 13K direct · 10K fmb research | $16 | $368K | Oct 13, 2026 |
Is this Franklin M Berger’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2013
Franklin M Berger bought shares on the open market in 2013, 2020, 2025 and 2026 across 3 companies. Sales in 2 of the 14 years since 2013.
Franklin M Berger reported 5 open-market purchases and 3 sales since 2013; purchases in 4 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 1×1 trade | — |
| 2025 | 2×2 trades | — |
| 2024 | — | 1×1 trade |
| 2022 | — | 2×2 trades |
| 2020 | 1×1 trade | — |
| 2013 | 1×1 trade | — |
Insider at 3 companies
- Retension Pharmaceuticals RTSN2026 · 1 purchase, 0 sales
- Atea Pharmaceuticals AVIR2020–2025 · 3 purchases, 3 sales
- Lineage Cell Therapeutics LCTX2013 · 1 purchase, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The companies behind these filings
- Atea Pharmaceuticals AVIR
Franklin M Berger reported 3 open-market purchases and 3 sales here, 2020 to 2025.
- Market value
- $352M
- Last close
- $4.39
- 12 months
- +43.5%
- Against the S&P 500
- +28.1 pts
- Retension Pharmaceuticals RTSN
Franklin M Berger reported 1 open-market purchase and 0 sales here, 2026.
- Last close
- $16.33
- Lineage Cell Therapeutics LCTX
Franklin M Berger reported 1 open-market purchase and 0 sales here, 2013.
- Market value
- $241M
- Last close
- $0.9528
- 12 months
- −42.3%
- Against the S&P 500
- −57.6 pts
- Net margin
- -436.5%
- Revenue (last year)
- $14.6M
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Franklin M Berger's trades
Has Franklin M Berger bought shares on the open market?
Franklin M Berger bought shares on the open market in 2013, 2020, 2025 and 2026 across 3 companies. Sales in 2 of the 14 years since 2013.
When did Franklin M Berger last buy or sell shares?
In SEC filings since 2013: the latest open-market purchase is from 2026; the latest open-market sale is from 2024.
Which companies has Franklin M Berger traded as an insider?
3 companies: Retension Pharmaceuticals (RTSN, 2026), Atea Pharmaceuticals (AVIR, 2020–2025), Lineage Cell Therapeutics (LCTX, 2013).